204930-37-0

Basic information

• Product Name: 5-BROMO-1,3-DICHLORO-2-METHYLBENZENE
• Synonyms: 5-BROMO-1,3-DICHLORO-2-METHYLBENZENE;Benzene, 5-broMo-1,3-dichloro-2-Methyl-
• CAS NO: 204930-37-0
• Molecular Formula: C₇H₅BrCl₂
• Molecular Weight: 239.92
• Mol File: 204930-37-0.mol
• Article Data: 5

Chemical Properties

• Boiling Point: 253.8±35.0 °C(Predicted)
• Appearance: /
• Density: 1.645±0.06 g/cm3(Predicted)
• Storage Temp.: 2-8°C
• CAS DataBase Reference: 5-BROMO-1,3-DICHLORO-2-METHYLBENZENE(CAS DataBase Reference)
• NIST Chemistry Reference: 5-BROMO-1,3-DICHLORO-2-METHYLBENZENE(204930-37-0)
• EPA Substance Registry System: 5-BROMO-1,3-DICHLORO-2-METHYLBENZENE(204930-37-0)

Safety Data

• Hazardous Substances Data: 204930-37-0(Hazardous Substances Data)

Usage

General Description

5-Bromo-1,3-Dichloro-2-Methylbenzene, also known as 1-bromo-3,5-dichloro-2-methylbenzene, is a chemical compound with the molecular formula C7H6BrCl2. It is a halogenated aromatic compound that is commonly used in the synthesis of pharmaceuticals and agrochemicals. The compound is a colorless liquid with a strong, aromatic odor and it is insoluble in water but soluble in organic solvents. It is primarily used as an intermediate in the production of various organic compounds and can also be used as a solvent or reagent in chemical reactions. The compound is considered to be hazardous and should be handled with caution in a well-ventilated area and with proper personal protective equipment.

Upstream product

• 7149-69-1 1,3-dichloro-2-methyl-5-nitrobenzene 
• 99-99-0 1-methyl-4-nitrobenzene 
• 54730-35-7 3,5-dichloro-4-methylaniline 

Downstream Products

• 956123-16-3 2-(4-bromo-2,6-dichloro-benzyl)-2-aza-spiro[4.5]decan-1-one 
• 274671-77-1 4-bromo-2,6-dichlorobenzyl alcohol 
• 111829-72-2 4-bromo-2,6-dichlorobenzaldehyde 
• 274671-76-0 5-bromo-2-(bromomethyl)-1,3-dichlorobenzene 

Relevant articles and documents

NOVEL COMPOUNDS AS ANTAGONISTS OR INVERSE AGONISTS FOR OPIOID RECEPTORS

This invention relates to novel compounds which are antagonists or inverse agonists at one or more of the opioid receptors, to pharmaceutical compositions containing them, to processes for their preparation, and to their use in therapy.

INHIBITORS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE 1

The present invention discloses novel compounds of Formula I: having 11 Beta-HSD type 1 antagonist activity, as well as methods for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprising compounds of Formula I, as well as methods of using the compounds and compositions to treat diabetes, hyperglycemia, obesity, hypertension, hyperlipidemia, metabolic syndrome, and other conditions associated with 11Beta-HSD type 1 activity. X-17377

Transition metal catalysed cross-coupling between benzylic halides and aryl nucleophiles. Synthesis of some toxicologically interesting tetrachlorobenzyltoluenes

The aryl-benzyl cross-coupling in the presence of copper-, nickel- and palladium-catalysts has been investigated with a number of chlorine- and methyl-substituted arylmetal compounds ArM (M = MgBr, ZnCl) and (substituted) benzylic halides ArCH2X. The results have been applied in the selective synthesis of some toxicologically interesting tetrachlorobenzyltoluenes.